These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 28508837)

  • 1. Colorectal cancer presenting as bone metastasis.
    Suresh Babu MC; Garg S; Lakshmaiah KC; Babu KG; Kumar RV; Loknatha D; Abraham LJ; Rajeev LK; Lokesh KN; Rudresha AH; Rao SA
    J Cancer Res Ther; 2017; 13(1):80-83. PubMed ID: 28508837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K
    Ann Surg Oncol; 2012 Oct; 19(11):3422-31. PubMed ID: 22576063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
    Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
    Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the preoperative levels of CEA in patients with colorectal cancer.
    Marchena J; Acosta MA; Garcia-Anguiano F; Simpson H; Cruz F
    Hepatogastroenterology; 2003; 50(52):1017-20. PubMed ID: 12845969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk factors for bone metastases in patients with colorectal cancer.
    Li AA; Cao ZY; Liu JM; Huang SH; Liu ZL
    Medicine (Baltimore); 2018 Oct; 97(40):e12694. PubMed ID: 30290664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer.
    Chang YT; Huang MY; Yeh YS; Huang CW; Tsai HL; Cheng TL; Wang JY
    PLoS One; 2016; 11(10):e0163264. PubMed ID: 27701415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in survival of colorectal cancer patients after surgery.
    Mehrkhani F; Nasiri S; Donboli K; Meysamie A; Hedayat A
    Colorectal Dis; 2009 Feb; 11(2):157-61. PubMed ID: 18462239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer-a multifactorial model of 191 patients].
    Jiang Q; Yan X; Wang K; Bao Q; Sun Y; Wang H; Jin K; Xing B
    Zhonghua Wai Ke Za Zhi; 2014 Mar; 52(3):171-4. PubMed ID: 24785453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
    Toiyama Y; Miki C; Inoue Y; Okugawa Y; Tanaka K; Kusunoki M
    Int J Cancer; 2009 Oct; 125(7):1657-62. PubMed ID: 19569242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Simple Scoring System Predicting the Survival Time of Patients with Bone Metastases after RT.
    Zhang WY; Li HF; Su M; Lin RF; Chen XX; Zhang P; Zou CL
    PLoS One; 2016; 11(7):e0159506. PubMed ID: 27438606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difficulty in diagnosis and different prognoses between colorectal cancer with ovarian metastasis and advanced ovarian cancer: An empirical study of different surgical adoptions.
    Lee KC; Lin H; ChangChien CC; Fu HC; Tsai CC; Wu CH; Ou YC
    Taiwan J Obstet Gynecol; 2017 Feb; 56(1):62-67. PubMed ID: 28254228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
    Sun L; Hu S; Yu L; Guo C; Sun L; Yang Z; Qi J; Ran Y
    Int J Cancer; 2016 Jun; 138(11):2724-31. PubMed ID: 26756179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of p53 positive in colorectal cancer: A retrospective cohort study.
    Wang P; Liang J; Wang Z; Hou H; Shi L; Zhou Z
    Tumour Biol; 2017 May; 39(5):1010428317703651. PubMed ID: 28468582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of perioperative change of CEA level in colorectal patients when pre-operative level is normal.
    Lan YT; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC; Yang SH
    Hepatogastroenterology; 2012 May; 59(115):717-20. PubMed ID: 22024225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prognostic model to predict clinical outcome in gastric cancer patients with bone metastasis.
    Park HS; Rha SY; Kim HS; Hyung WJ; Park JS; Chung HC; Noh SH; Jeung HC
    Oncology; 2011; 80(1-2):142-50. PubMed ID: 21677462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of CEA and CA19-9 combination as a prognostic indicator and for recurrence monitoring in patients with stage II colorectal cancer.
    Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
    Anticancer Res; 2014 Jul; 34(7):3753-8. PubMed ID: 24982398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in survival of colorectal cancer patients with synchronous liver metastasis.
    Zhang S; Gao F; Luo J; Yang J
    Colorectal Dis; 2010 Aug; 12(8):754-61. PubMed ID: 19508508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of the serum carcinoembryonic antigen kinetic for chemotherapy monitoring in patients with unresectable metastasis of colorectal cancer.
    Iwanicki-Caron I; Di Fiore F; Roque I; Astruc E; Stetiu M; Duclos A; Tougeron D; Saillard S; Thureau S; Benichou J; Paillot B; Basuyau JP; Michel P
    J Clin Oncol; 2008 Aug; 26(22):3681-6. PubMed ID: 18669452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.